| Question 22 | Electrical injuries - examination findings and complications |
| Question 19 | Refractory vasodilatory shock, except its an overdose |
| Question 1 | Heat stroke: complications and their management |
| Question 10 | Acute and chronic lithium toxicity |
| Question 29 |
| Question 9 |
| Question 15 | Sympathomimetic toxicity - this time, MDMA |
| Question 14 | Immersion submersion and drowning: resuscitation and outcomes |
| Question 3 |
| Question 21 |
| Question 9 |
| Question 30 | |
| Question 27 | |
| Question 16 |
| Question 18.3 | Toxic alcohols - features of methanol toxicity |
| Question 15.2 | Tricyclic antidepressant overdose - an ECG exercise |
| Question 14 | Fluid resuscitation for the burns patient: causes of shock |
| Question 22 |
| Question 13 | |
| Question 11 | Sympathomimetic toxicity - methamphetamine |
| Question 27 | |
| Question 7 | Toxins and their antidotes: digoxin, TCAs, beta blockers and lignocaine |
| Question 2 | Causes of shock in burns: a variant of causes of shock in trauma |
| Question 1 | Snake bite envenomation - a brown snake, probably Pseudonaja textilis |
| Question 29 |
| Question 26 | |
| Question 8 | Salicylate toxicity in unusual detail |
| Question 28 | |
| Question 3 | High voltage electrical injuries. Also, a little about rhabdomyolysis. |
| Question 17 | Salicylate overdose, with a characteristic blood gas |
| Question 26 | |
| Question 23 | Heat stroke, broadly (pathophysiology, diagnosis, management, prognosis) |
| Question 21.3 | Toxic alcohols: mechanisms and management of methanol toxicity |
| Question 13.1 | The characteristic biochemistry of propofol infusion syndrome |
| Question 21 | |
| Question 10.1 |
| Question 9 |
| Question 18.1 | Organophosphate poisoning: clinical features, antidotes, cholinesterase mixing studies. |
| Question 8 | Iron poisoning - clinical features and a detailed discussion of management |
| Question 11 | |
| Question 4 | Digoxin toxicity (in some considerable detail). |
| Question 25 | |
| Question 18 | Important clinical features in the management of a burns patient |
| Question 15.4 | Activated charcoal-induced bowel obstruction (CT image) |
| Question 10 | Salicylate overdose, with a characteristic blood gas |
| Question 29 | |
| Question 26 | Physiologic consequences of burns: specifically, the effects on ventilation and gas exchange. |
| Question 29 | |
| Question 28 |
| Question 20 | Propofol infusion syndrome. Risk factors, laboratory evidence, management. |
| Question 1 | Management of a burns patient: classification of burns and estimation of %BSA |
| Question 30 | |
| Question 28.2 | Tricyclic antidepressant overdose: role of sodium bicarbonate |
| Question 28.1 | |
| Question 18 | Iron poisoning - clinical signs, investigations, characteristic ABG findings |
| Question 19.1 | |
| Question 1 |
| Question 14.2 | |
| Question 14.1 |
| Question 2 |
| Question 14 | Calcium channel blocker overdose ... compared with a beta-blocker overdose. |
| Question 13 | Pathophysiology and clinical features of smoke inhalation injury. |
| Question 2 |
| Question 1d | Supportive management of the overdose: part of the "Toxicological Primary Survey" |
| Question 1c | |
| Question 1b | Decontamination following overdose: charcoal, PEG, lavage, etc... |
| Question 1a | Immediate management of the undifferentiated overdose: the "Toxicological Primary Survey" |
| Question 10 | Malignant hyperthermia - diagnostic features, complications and treatment |
| Question 7 |
| Question 5 |
| Question 7 | Drug withdrawal states: classical syndromes and their management |
| Question 11 | Airway burns: mechanisms, symptoms, management. |
| Question 1 |
| Question 6 | Corrosive ingestion: what might be the possible complications |